Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications

    Pharmacognosy Communications, Vol 12, Issue 1, Jan-Mar, 2022

    Editorial
    I.E. Cock1,2,*Editor-In-Chief1Centre for Planetary Health and food Security, Nathan Campus, Griffith University, Brisbane, Queensland, AUSTRALIA.2School of Natural Sciences, Nathan Campus, ...
    Read More
    A Look at the Role of Mucilage at the Industrial Level
    Exploration of Streptomyces hygroscopicus Secondary Metabolite Compound as a Development of Antimalarial Drug Candidate
    Melinda Violita1, Ajeng Widyastuti1, Cahya Pandya Astami2, Rivo Yudhinata Brian Nugraha3, Uswatun Khasanah4,* 1Pharmacy Study Program, Faculty of Medicine, Universitas ...
    Read More
    A Look at the Role of Mucilage at the Industrial Level
    A Look at the Role of Mucilage at the Industrial Level
    María Paz Villegas Calero, Alejandro Esquivel Álvarez, Elías Quesada Morales, María Fernanda Rojas Salas, Marianela Chavarría-Rojas, German Madrigal Redondo* Instituto ...
    Read More
    Antibacterial Activity of Harpagophytum procumbens (Burch.) DC. ex Meisn. Root Extracts against Gastrointestinal Pathogens and Bacterial Triggers of Autoimmune Diseases
    Antibacterial Activity of Harpagophytum procumbens (Burch.) DC. ex Meisn. Root Extracts against Gastrointestinal Pathogens and Bacterial Triggers of Autoimmune Diseases
    Alysha Bromley1, Ian E Cock1,2,* 1School of Environment and Science, Griffith University, Nathan, Queensland, AUSTRALIA. 2Centre for Planetary Health and ...
    Read More
    Extracts of Lomandra hystrix Labill. Aerial Parts Lack Antibacterial Activity and are Non-toxic in vitro
    Extracts of Lomandra hystrix Labill. Aerial Parts Lack Antibacterial Activity and are Non-toxic in vitro
    Getmore Rumbudzai Chikowe1, Lindiwe Nomathemba Mpala1, I E Cock1,2,* 1Environmental Futures Research Institute, Griffith University, Brisbane, Queensland, AUSTRALIA. 2School of ...
    Read More
    Figure 1: Student grade outcomes in 2010 – 2013 expressed as a proportion of each cohort. HD = high distinction (≄ 85 %); D = distinction (75-84.9 %); C = credit (65-74.9 %); P = pass (50-64.9 %); F = fail (≀ 49.9 %).
    Improving Student Outcomes and Perceptions in First Year Biosciences by Enhancing Engagement: A Case Study
    Ian Cock1,2,* 1School of Environment and Science, Griffith University, Brisbane, AUSTRALIA. 2Centre for Planetary Health and Food Security, Griffith University, ...
    Read More
    Green Tea Consumption may Protect against Cancer
    The Janus Corner
    I E Cock1,2,* 1School of Environment and Science, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA. 2Centre for Planetary Health ...
    Read More
    Figure 1: Tasmannia lanceolata (Poir) A.C.Sm. (Family Winteraceae), commonly known as Tasmanian pepper or mountain pepper berry, is shrub which is endemic to the woodlands and cool temperate rainforests of Tasmania and the south-eastern region of the Australian mainland. The leaves, berries and bark of this plant have traditional uses as a food flavouring, and as a medicinal plant. Australian Aborigines used T. lanceolata as a therapeutic agent to treat stomach disorders and as an emetic, as well as general usage as a tonic.1 That study reported that T. lanceolata was used by Australian Aborigines for the treatment and cure of skin disorders, venereal diseases, colic, stomach ache and as a quinine substitute. Several of these traditional uses have been validated in recent publications. The antibacterial properties of T. lanceolata have been particularly well reported against a wide variety of bacterial species.2-6 Similarly, the related species Tasmannia stipatata7 and Pseudowintwera colorata (Raoul) Dandy8 have also been reported to inhibit the growth of multiple bacteria. T. lanceolata extracts have also been reported to inhibit the growth of the gastrointestinal protozoal parasite Giadria duodenalis.6,9 Similar extracts also inhibit the proliferation of several human cancer cell lines.6,10
    Medicinal Plant Images
    I E Cock1,2,* 1Environmental Futures Research Institute, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA. 2School of Natural Sciences, Nathan ...
    Read More
    Upcoming Events
    Upcoming Events
    Disclaimer: The following conference dates and details have been provided using currently available information. Due to the rapidly changing nature ...
    Read More
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up